Nohemí Núñez-Rodríguez

Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy

R. Ribas-Aparicio, J. Zenteno, A. Gómez-Delgado, 2021, Pharmacogenetics and genomics.

Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients

J. Gaytán-Martínez, J. A. Mata-Marín, Nohemí Núñez-Rodríguez, 2017, Drugs in R&D.

Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients

J. Gaytán-Martínez, J. A. Mata-Marín, J. Sandoval-Ramírez, 2015, AIDS Research and Therapy.

Dyslipidemia and Fasting Glucose Impairment among HIV-InfectedPatients 48-Weeks after the First Antiretroviral Regimen

A.Lara, J. Juan, J. Gaytán-Martínez, 2015 .

Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.

Gloria Huerta García, J. Gaytán-Martínez, J. A. Mata-Marín, 2016, Journal of Infection in Developing Countries.